PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd (NYSE: POAS)

Phaos Technology Holdings (Cayman) Limited specializes in the development, assembly, and commercialization of advanced microscopy-related solutions. The company leverages its patented microsphere-assisted technology to enhance the magnification capabilities of traditional optical microscopes, enabling users to observe details beyond the conventional 200nm optical limit. Phaos Technology's product portfolio includes super-resolution imagers, specialized microscopes, and three-dimensional real-time image magnifiers, all designed to meet the precision measurement and magnification needs of various industries. The company's proprietary software, integrated with its hardware offerings, incorporates Artificial Intelligence (AI) components to facilitate pattern recognition for research, quality assurance, and diagnostics.

Phaos Technology generates revenue primarily through the sale of its microscopy products and complementary software solutions. The company's products are distributed through a network of distributors, with a significant focus on the Singapore market and expanding reach into Southeast Asia and South Asia. For the financial years ended April 30, 2023, and April 30, 2024, microscopy products contributed 73.9% and 99.9% of the company's revenue, respectively. The company reported revenue of S$650,797 for the financial year ended April 30, 2023, and S$1,882,803 for the financial year ended April 30, 2024, reflecting an 189.3% growth in revenue.

The company operates through the following segments: Optonano series, PT-Industrial (PT-I) series, PT-Metrology (PT-M) series, PT-Biology (PT-B) series, PT-Stereo (PT-S) series, and PT-Zoom (PT-Z) series.
• Optonano series: This segment offers super-resolution imaging down to 137nm and high-speed data acquisition. The Optonano series enables users to view live and still images with ease, featuring a 100x lens and super-resolution applications for constructing high-quality images of larger sample areas. The series includes an in-built auto focus for optimized imaging.
• PT-Industrial (PT-I) series: Designed for material study, failure analysis, quality control, inspection, and manufacturing, the PT-I series offers various observation methods, including Brightfield, Darkfield, Polarization, Phase Contrast, and Differential Interference Contrast (DIC). The hardware can be customized to address specific customer needs, integrating seamlessly into existing systems.
• PT-Metrology (PT-M) series: This segment provides quick dimensional measurements with a single key operation. The PT-M series features a Double Telecentric Optical Lens for accurate measurement across the entire depth of field, a motorized Z-Axis and XY Stage, and a one-key measurement function for ease of use.
• PT-Biology (PT-B) series: Developed for the biomedical sector, particularly pathology, the PT-B series includes infinity plan achromatic objectives and wide field eyepieces. It offers Brightfield, Phase Contrast, and Polarization observation methods, with a built-in field diaphragm, adjustable brightness, high image contrast, and a 40-1600x magnification range.
• PT-Stereo (PT-S) series: This segment features a stereo microscope designed for quality assurance and control applications. The PT-S series offers a long working distance of 110mm, a wide zoom range from 0.7x to 6.3x, and adjustable LED light sources for better imaging.
• PT-Zoom (PT-Z) series: Providing a three-dimensional magnified view of samples, the PT-Z series offers motorized 360° 3D real-time image observation. It features a long working distance for a large field of view, high-definition imaging quality, and adjustable LED light sources.

Phaos Technology Holdings (Cayman) Limited operates in the competitive microscopy equipment industry, facing competition from well-established brands such as Keyence Corp., Nikon Corp., Olympus Corp., and Hirox Co. Ltd. The company differentiates itself through strong relationships with suppliers and customers, an experienced management team, integrated software solutions, innovative turn-key solutions, an adaptive business model, and reliable after-sales support. The company's strategic focus involves strengthening its market position in Singapore and expanding into Southeast Asia, leveraging its unique technology and customer-centric approach to maintain a competitive edge.

The company's diverse customer base includes manufacturing companies, biomedical service providers, and research and development (R&D) institutions. Manufacturing companies use Phaos Technology's solutions for quality assurance and control in fields such as Printed Circuit Boards, electronics, precision engineering, injection molding, and QA/QC. Biomedical service providers purchase the systems to offer services to end customers like hospitals and clinics, while R&D institutions utilize the systems for research and innovation activities. The company's top five customers accounted for 86% and 91% of total revenue for the financial years ended April 30, 2023, and 2024, respectively, highlighting the concentration of its customer base.